Our Services Across Asia Pacific

Cisema delivers expert regulatory affairs, quality assurance and clinical development support for companies entering and operating in the Asia Pacific region. With 16 offices across 13 countries, we provide local insights, global coordination, and deep industry experience to help you meet compliance requirements and achieve faster market access.

Our Regulatory Affairs and Quality experts are fluent in a wide range of Asian and European languages, including Chinese, English, German, Japanese, Korean, Vietnamese, Thai, Bahasa Malay and Indonesian, French, Italian and Spanish, ensuring seamless communication across borders and time zones. Whether your headquarters is in North America, Europe, or Asia, we help bridge language and cultural gaps for smooth project execution.

Cisema Countries Covered
Drug products inside delivery device

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Read the Latest Regulatory News

View More

China GACC Revises Filing Rules for Imported Food Importers & Exporters

GACC has simplified filing for imported-food importers and exporters while strengthening port verification, change reporting and ongoing supervision.

November 18, 2026
China GACC Revises Filing Rules for Imported Food Importers & Exporters

Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

Beijing's pilot allows companies to download and print approved import clearance documents digitally, reducing paperwork while maintaining existing regulatory requirements.

November 18, 2026
Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices

China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

November 16, 2026
China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices
Two Chinese laboratory professionals check a benchtop blood analyzer as one loads a rack of capped sample tubes.

India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

November 16, 2026
India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated
Two Indian clinicians review a chest X-ray on a tablet, where diagnostic software has flagged an area in one lung.

Singapore Updates GN-15 Medical Device Registration Guidance

Singapore’s HSA has revised GN-15 medical device registration guidance, updating submission templates, SaMD requirements and post-market expectations.

November 12, 2026
Singapore Updates GN-15 Medical Device Registration Guidance

China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III

Find out which imported veterinary biological products need updated testing, revised registration standards, or regulatory approval before May 2027.

November 3, 2026
China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III
Previous
Previous

Contact Cisema for Support in Successfully Reaching Your Regulatory Goals in Asia Pacific

Talk to an Expert